May 20, 2024 | Commentary
In 2019, the Committee moved legislation to prevent brand drug companies from amassing superfluous patents around their products—a strategy that, as we’ve written before, is uniquely problematic in the United States.
May 13, 2024 | Events
On May 13, experts convened at AEI to discuss the United States’ fiscal trajectory: how we got here, where we’re going, and what we can do to reduce the burden of debt for future generations.
Apr 25, 2024 | Op-Eds
On December 22, 2017, President Donald Trump signed into law the Tax Cuts and Jobs Act (TCJA).
Apr 24, 2024 | Commentary
Fourteen years ago, Congress established a regulatory pathway for biosimilars, direct competitors to branded biologic drugs.
Apr 23, 2024 | Commentary
Insulin, a drug first developed more than 100 years ago, has experienced a surge in political interest in recent years following dramatic price hikes.